106 related articles for article (PubMed ID: 2517324)
1. Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist.
Mampaso FM; Egido J; Martínez-Montero JC; Bricio T; González E; Cobo ME; Pirotzky E; Braquet P; Hernando L
Nephrol Dial Transplant; 1989; 4(12):1037-44. PubMed ID: 2517324
[TBL] [Abstract][Full Text] [Related]
2. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
[TBL] [Abstract][Full Text] [Related]
3. Evidence suggesting a role for platelet-activating factor (PAF) in experimental nephrotic syndrome.
Egido J; Mampaso F; Gómez-Chiarri M; González E; Ortíz A; Lerma JL; Robles A; Braquet P; Hernando L
Int J Tissue React; 1990; 12(4):213-20. PubMed ID: 2178155
[TBL] [Abstract][Full Text] [Related]
4. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
Whiteside C; Prutis K; Cameron R; Thompson J
Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
[TBL] [Abstract][Full Text] [Related]
5. Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis.
Eddy AA; Michael AF
Kidney Int; 1988 Jan; 33(1):14-23. PubMed ID: 3258389
[TBL] [Abstract][Full Text] [Related]
6. Involvement of lipid mediators in the pathogenesis of experimental nephrosis in rats: its pharmacological modulation.
Egido J; Ortiz A; Goméz-Chiarri M; Lerma JL; Robles A; Bustos C; Gómez-Guerrero C; Alonso J; González E
Ren Fail; 1991; 13(2-3):95-101. PubMed ID: 1659728
[TBL] [Abstract][Full Text] [Related]
7. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.
Eddy AA; McCulloch L; Liu E; Adams J
Am J Pathol; 1991 May; 138(5):1111-23. PubMed ID: 2024704
[TBL] [Abstract][Full Text] [Related]
8. Protection of platelet-activating factor-induced acute renal failure by BN 52021.
Pirotzky E; Colliez P; Guilmard C; Schaeverbeke J; Mencia-Huerta JM; Braquet P
Br J Exp Pathol; 1988 Apr; 69(2):291-9. PubMed ID: 3377967
[TBL] [Abstract][Full Text] [Related]
9. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
10. Role of leucocyte adhesion molecules in aminonucleoside of puromycin (PAN)-associated interstitial nephritis.
Martín A; Escudero E; Mampaso F
Clin Exp Immunol; 1997 Apr; 108(1):78-87. PubMed ID: 9097915
[TBL] [Abstract][Full Text] [Related]
11. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis.
Bustos C; González-Cuadrado S; Ruiz-Ortega M; Gómez-Guerrero C; González E; Plaza JJ; Egido J
Clin Exp Immunol; 1995 Dec; 102(3):608-13. PubMed ID: 8536380
[TBL] [Abstract][Full Text] [Related]
13. Interstitial nephritis induced by protein-overload proteinuria.
Eddy AA
Am J Pathol; 1989 Oct; 135(4):719-33. PubMed ID: 2801886
[TBL] [Abstract][Full Text] [Related]
14. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
Diamond JR; Anderson S
Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
[TBL] [Abstract][Full Text] [Related]
15. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
Kaplan BS; Renaud L; Drummond KN
Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats.
Rangan GK; Wang Y; Tay YC; Harris DC
Kidney Int; 1999 Jul; 56(1):118-34. PubMed ID: 10411685
[TBL] [Abstract][Full Text] [Related]
18. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
Rodriguez-Barbero A; López-Novoa JM; Arévalo M
Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
[TBL] [Abstract][Full Text] [Related]
19. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
20. The relationship of adhesion molecules and leukocyte infiltration in chronic tubulointerstitial nephritis induced by puromycin aminonucleoside in Wistar rats.
Wu JC; Fan GM; Kitazawa K; Sugisaki T
Clin Immunol Immunopathol; 1996 Jun; 79(3):229-35. PubMed ID: 8635280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
